MoviPrep News
Salix Pharmaceuticals to Present at BMO Capital Markets Conference - PharmaLive.com (press release)
... OSMOPREP(TM) (sodium phosphate monobasic monohydrate, USP and sodium phosphate dibasic anhydrous, USP) Tablets, MOVIPREP(R) (PEG 3350, Sodium Sulfate, ...
Salix's profit, drug sales rise - News & Observer
In the past year, Salix has added two products for its salespeople to promote to doctors: colon cleanser Moviprep and a liquid version of the antacid Pepcid ...
Salix Pharmaceuticals to Present at Two Investment Conferences ... - PharmaLive.com (press release)
... OSMOPREP(TM) (sodium phosphate monobasic monohydrate, USP and sodium phosphate dibasic anhydrous, USP) Tablets, MOVIPREP(R) (PEG 3350, Sodium Sulfate, ...
Salix Pharmaceuticals Announces Imminent Launch of Visiclear ® in ... - Business Wire (press release)
... OSMOPREP™ (sodium phosphate monobasic monohydrate, USP, and sodium phosphate dibasic anhydrous, USP) Tablets, MOVIPREP ® (PEG-3350, sodium sulfate, ...
Salix Pharmaceuticals Announces Imminent Launch of Visiclear(R) in ... - Genetic Engineering News (press release)
... USP) Tablets, MOVIPREP(R) (PEG-3350, sodium sulfate, sodium chloride, potassium chloride, sodium ascorbate and ascorbic acid for Oral Solution), ...
Salix grows revenue, but profit shrinks on R&D costs - Triangle Business Journal
... ulcerative colitis treatment Colazal and travelers' diarrhea drug Xifaxan, jumped, as did sales of the company's bowel-cleansing drug line - Moviprep, ...
Salix Pharmaceuticals Reports 1Q2007 Results - Genetic Engineering News (press release)
MOVIPREP, OSMOPREP and VISICOL at quarter end commanded an impressive 23% share of the prescription bowel cleansing market and we anticipate our share of ...
MoviPrep RSS Feed